GoodRx Holdings Appoints Christopher A. McGinnis as New CFO to Enhance Leadership

GoodRx Strengthens Leadership with New CFO Appointment

GoodRx Holdings, a prominent prescription savings platform in the U.S., announces the appointment of Christopher A. McGinnis as its new Chief Financial Officer, effective February 4, 2025. McGinnis joins the company with an impressive 30-year track record in finance within the healthcare sector, enriching GoodRx's leadership team at a time when the company continues to innovate in the healthcare savings space. His previous role as CEO of CitizensRx allowed him to gain significant experience in pharmacy benefit management, which is crucial to GoodRx's mission of making medications more accessible and affordable for Americans.

In his extensive career, McGinnis has held critical executive positions that align well with GoodRx’s operational goals. As Chief Financial Officer and Executive Vice President of Operations at Lumeris / Essence Healthcare, he oversaw health plan operations and developed value-based services, thereby enhancing healthcare delivery. Moreover, his time as Chief Accounting Officer at Express Scripts Holding Company has equipped him with in-depth knowledge of accounting practices, SEC reporting, and tax strategy within one of the largest pharmacy benefit managers in the nation. Wendy Barnes, CEO of GoodRx, expresses strong enthusiasm for McGinnis's arrival, emphasizing that his financial acumen and healthcare expertise will be essential for supporting the company’s growth trajectory.

GoodRx serves approximately 30 million consumers and over one million healthcare professionals each year, providing substantial savings on prescriptions at more than 70,000 pharmacies across the country. Since its founding in 2011, the platform has enabled consumers to save over $75 billion on medications. McGinnis’s commitment to GoodRx's mission to simplify healthcare aligns seamlessly with the company’s goals, positioning him as a pivotal figure in driving its future initiatives and ensuring continued success in the competitive healthcare market.

In addition to his financial expertise, McGinnis's appointment reflects GoodRx's strategic focus on enhancing its operational capabilities in the evolving healthcare landscape. The company maintains a dedicated investor relations website to ensure transparency and compliance with regulatory obligations, reinforcing its commitment to stakeholders. As GoodRx prepares for the future, the integration of McGinnis into its executive team appears to be a transformative step in advancing its mission to offer affordable healthcare solutions.